Sanofi boosts its mRNA capabilities with Translate Bio acquisition by Lucy Parsons | Aug 3, 2021 | News | 0 Sanofi will acquire Translate Bio for approximately $3.2bn, or $38.00 per share in cash Read More
Sanofi pays $300m upfront to expand deal with Translate Bio by Selina McKee | Jun 23, 2020 | News | 0 The firms are working on the development of mRNA vaccines Read More